OMCL
Omnicell, Inc. · Healthcare · Medical - Healthcare Information Services
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -7.7% ·
Aktienfluss +5.5% ·
neue Nettopositionen -8.3%
— Formel
Konzentrierte Akkumulation — steigende Anteile bei weniger Haltern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2024
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 99 | +2 | 36.97M | $1.52B | +8 | −6 |
| Q1 2026 | 100 | +1 | 36.98M | $1.23B | +6 | −5 |
| Q4 2025 | 99 | +2 | 40.13M | $1.82B | +2 | — |
| Q3 2025 | 18 | 0 | 22.98M | $699.67M | +1 | −1 |
| Q2 2025 | 15 | -1 | 21.34M | $627.32M | +1 | −2 |
| Q1 2025 | 13 | -1 | 6.74M | $235.79M | — | −1 |
| Q4 2024 | 14 | +1 | 6.20M | $275.97M | +1 | — |
| Q3 2024 | 12 | -1 | 3.89M | $169.70M | — | −1 |
| Q2 2024 | 13 | — | 3.69M | $99.83M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passiv) | 1.10M | +0.3% | $48.18M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passiv) | 1.10M | +0.3% | $48.18M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | D. E. Shaw & Co. ✦ | 940.75K | -13.5% | $41.02M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 4 | D. E. Shaw & Co. ✦ | 940.75K | -13.5% | $41.02M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 5 | D. E. Shaw & Co. ✦ | 940.75K | -13.5% | $41.02M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 423.04K | +1.1% | $18.44M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 423.04K | +1.1% | $18.44M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 423.04K | +1.1% | $18.44M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 423.04K | +1.1% | $18.44M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Millennium Management ✦ | 386.23K | +298.2% | $16.84M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Millennium Management ✦ | 386.23K | +298.2% | $16.84M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 300.58K | -22.9% | $13.11M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 300.58K | -22.9% | $13.11M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Marshall Wace ✦ | 263.05K | +338.6% | $11.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | Marshall Wace ✦ | 263.05K | +338.6% | $11.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | Marshall Wace ✦ | 263.05K | +338.6% | $11.47M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Renaissance Technologies ✦ | 254.51K | +93.8% | $11.10M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 98.27K | -20.7% | $4.28M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 40.88K | +1.1% | $1.78M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | Gotham Asset Management ✦ | 40.20K | +2.2% | $1.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 21.83K | -55.5% | $951,919 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 21.83K | -55.5% | $951,919 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 21.83K | -55.5% | $951,919 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 24 | Bridgewater Associates ✦ | 17.93K | -53.2% | $781,704 | 0.0% | ▼ Trim | 2 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| PRIMECAP Management | $3.00M | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 2 Inhaber, 5.77M Anteile, $5.60M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.